Share:

Lymphedema Treatment Act

HR 930 : To amend title XVIII of the Social Security Act to provide for Medicare coverage of certain lymphedema compression treatment items as items of durable medical equipment.

STATUS

This bill is from the 115th Congress.

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. February 7, 2017

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. February 7, 2017

Referred to the Subcommittee on Health. February 10, 2017

Referred to the Subcommittee on Health. February 21, 2017

Read the Official Bill Text

Currently, Medicare does not cover one of the most critical therapeutic treatments for lymphedema, an incurable disease most commonly developed after radiation and chemotherapy. Lymphedema is a chronic disease which causes an accumulation of fluid and swelling in the lymph nodes or lymphatic vessels, generally occurring in extremities of the body. As a result, many patients suffer from recurrent infections, progressive degradation in their condition and eventual disability because they cannot afford doctor-prescribed compression garments which alleviates severe swelling and other symptoms of lymphedema.  

This legislation would enable Medicare coverage for doctor-prescribed compression therapy supplies which are the foundation for treating this disease. Inadequately treated lymphedema is progressive, leading to costly complications. Coverage of these medically necessary supplies will improve patient care while reducing total healthcare costs associated with this chronic and potentially debilitating disease.